Micromedic Technologies' CCL3-AAB kit is a diagnostic kit for type 1 diabetes in pediatric and juvenile patients, utilizing a novel biomarker- autoantibodies (AABs) to CCL3 (previously known as MIP1-alpha). The kit is in ELISA format and allows for the testing of up to 40 samples simultaneously. The kit received its CE mark and is approved for IVD usage in Europe, as well for Research Use Only (RUO) in the United States.
No comments:
Post a Comment